This is a business-compounding case, not a heroic
rerating case. RDVT already has profitable products, strong retention, and mixed subscription plus transactional capture, so it can grow by moving from lookups into embedded verification workflows. If Snowflake, home healthcare, and one good use of the August cash prove out, revenue can roughly triple while the revenue multiple settles below today's peak but stays premium to generic software.